GeneDx Hldgs (NASDAQ:WGS) reported quarterly earnings of $0.01 per share which beat the analyst consensus estimate of $(0.19) by 105.26 percent. This is a 98 percent decrease over earnings of $0.50 per share from the same period last year. The company reported quarterly sales of $114.440 million which beat the analyst consensus estimate of $111.011 million by 3.09 percent. This is a 11.44 percent increase over sales of $102.692 million the same period last year.